ストックスクリーナーアプリを入手
94.09
2.79%
2.55
前日終値:
$91.54
開ける：
$90.85
24時間の取引高:
232.88K
Relative Volume:
1.27
時価総額：
$1.11B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+12.39%
1か月 パフォーマンス:
+24.37%
6か月 パフォーマンス:
+309.09%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$90.00
$95.43
1週間の範囲:
$80.64
$101.94
52週間の値動き範囲:
$11.17
$101.94
Palvella Therapeutics Inc Stock (PVLA) Company Profile
名前
Palvella Therapeutics Inc
セクター
電話
(484) 253-1461
住所
353 W. LANCASTER AVENUE, WAYNE
PVLA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PVLA
Palvella Therapeutics Inc
|
94.09 | 1.08B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2025-09-09 | 開始されました | Oppenheimer | Outperform |
| 2025-08-06 | 開始されました | Raymond James | Outperform |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-04-09 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-26 | 開始されました | Stifel | Buy |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2025-02-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-02-05 | 開始されました | TD Cowen | Buy |
| 2024-12-26 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-03-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | 開始されました | Robert W. Baird | Outperform |
| 2018-03-19 | 開始されました | Evercore ISI | Outperform |
| 2018-03-19 | 開始されました | Jefferies | Buy |
| 2018-01-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-30 | 開始されました | Rodman & Renshaw | Buy |
| 2016-08-05 | 再開されました | ROTH Capital | Buy |
| 2015-08-12 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-07-27 | 開始されました | Oppenheimer | Outperform |
| 2015-07-22 | 開始されました | ROTH Capital | Buy |
すべてを表示
Palvella Therapeutics Inc (PVLA) 最新ニュース
Is Frog Cellsat Limited Positioned to Benefit From Secular ShiftsCandlestick Trading Patterns & Discover Your Financial Freedom Formula - earlytimes.in
Palvella Therapeutics stock hits 52-week high at $98.60 By Investing.com - Investing.com Canada
Will Palvella Therapeutics Inc. (PI6) stock rise with strong economyQuarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com
Palvella Therapeutics (NASDAQ:PVLA) Shares Gap Up Following Analyst Upgrade - Defense World
Palvella Therapeutics (NASDAQ:PVLA) Stock Rating Upgraded by Raymond James Financial - Defense World
Palvella Therapeutics Inc (PVLA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Why Palvella Therapeutics Inc. stock remains a top recommendationRecession Risk & Low Drawdown Investment Ideas - newser.com
Will Palvella Therapeutics Inc. stock continue dividend increasesWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - newser.com
Can Palvella Therapeutics Inc. stock beat analyst upgradesJuly 2025 Volume & AI Driven Stock Reports - newser.com
Raymond James Upgrades Palvella Therapeutics (PVLA) - Nasdaq
Can momentum traders help lift Palvella Therapeutics Inc.2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com
Raymond James upgrades Palvella Therapeutics stock rating to Strong Buy By Investing.com - Investing.com Canada
Why global investors buy Palvella Therapeutics Inc. (PI6) stockIndex Update & Technical Pattern Based Buy Signals - newser.com
Can Palvella Therapeutics Inc. stock maintain growth trajectory2025 Risk Factors & Expert Approved Trade Ideas - newser.com
Raymond James upgrades Palvella Therapeutics stock rating to Strong Buy - Investing.com India
Can Palvella Therapeutics Inc. stock sustain market leadership2025 Big Picture & Long-Term Capital Growth Ideas - newser.com
What MACD and RSI say about Palvella Therapeutics Inc.Portfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com
How geopolitical risks impact Palvella Therapeutics Inc. (PI6) stock2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Can Palvella Therapeutics Inc. stock withstand economic slowdownJuly 2025 Final Week & Technical Pattern Recognition Alerts - newser.com
Palvella Races Toward Key 2026 Readouts as Rare-Disease Pipeline Expands Rapidly - MyChesCo
Cantor Fitzgerald Issues Negative Estimate for PVLA Earnings - Defense World
Palvella Therapeutics (PVLA) Gets a Buy from LifeSci Capital - The Globe and Mail
Can Palvella Therapeutics Inc. stock deliver consistent earnings growthJuly 2025 Setups & AI Powered Market Entry Ideas - newser.com
Why Palvella Therapeutics Inc. (PI6) stock is favored by hedge fundsInflation Watch & Fast Entry Momentum Alerts - newser.com
Lifesci Capital Has Negative Outlook of PVLA FY2025 Earnings - Defense World
HC Wainwright Issues Pessimistic Forecast for PVLA Earnings - Defense World
Why Palvella Therapeutics Inc. (PI6) stock is upgraded to buyPortfolio Value Summary & Stepwise Trade Execution Plans - newser.com
Canaccord Genuity Maintains Palvella Therapeutics (PVLA) Buy Recommendation - Nasdaq
Palvella Therapeutics Inc (PVLA) 財務データ
Palvella Therapeutics Inc (PVLA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):